Offer - Urjas Oil for just ₹ 1 X
Nebilong 5 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of High BP.
Medical history of the patient along with age and gender determines the dosage of Nebilong 5 Mg Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
While these are the most often observed Nebilong 5 Mg Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Nebilong 5 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Nebilong 5 Mg Tablet's effect during pregnancy is Severe and Severe while nursing. Further, the section on Nebilong 5 Mg Tablet related warnings talks about Nebilong 5 Mg Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease) must refrain from the use of Nebilong 5 Mg Tablet since this can cause severe adverse effects. The section on Nebilong 5 Mg Tablet contraindications lists all such conditions.
Additionally, Nebilong 5 Mg Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Nebilong 5 Mg Tablet is not safe while driving, and is is not addictive in nature.
Nebilong 5 Mg Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Nebilong 5 Mg Tablet safe for pregnant women?
Nebilong should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Nebilong 5 Mg Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Nebilong. It should only be taken after medical advice.
What is the effect of Nebilong 5 Mg Tablet on the Kidneys?
Nebilong may have mild side effects on the kidneys.
What is the effect of Nebilong 5 Mg Tablet on the Liver?
Nebilong may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Nebilong 5 Mg Tablet on the Heart?
Side effects of Nebilong rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Nebilong 5 Mg Tablet unless your doctor advises you to do so -
Is this Nebilong 5 Mg Tablet habit forming or addictive?
Nebilong 5 Mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Nebilong 5 Mg Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Nebilong 5 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, Nebilong 5 Mg Tablet is not used to treat mental disorders.
Interaction between Food and Nebilong 5 Mg Tablet
When consumed with certain foods, Nebilong 5 Mg Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Nebilong 5 Mg Tablet
Consumption of alcohol and Nebilong 5 Mg Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897